Serious adverse event

Results: 260



#Item
241Pharmaceutical sciences / Research / Pharmaceutical industry / Adverse effect / Serious adverse event / Clinical Trials Directive / Pharmacovigilance / Clinical trial / Adverse event / Clinical research / Pharmacology / Health

Form for submission of comments

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-10-09 09:32:48
242Medicine / Health / Pharmacology / Drug safety / Design of experiments / Clinical trial / Serious adverse event / Adverse event / Clinical Trials Directive / Clinical research / Research / Pharmaceutical industry

Public consultation on re-written guidance on SUSAR (suspected unexpected serious adverse reaction) reporting during Clinical Trials September 2010 Cancer Research UK welcomes the opportunity to comment on the re-written

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-10-09 09:32:48
243Pharmaceutical sciences / Health / Pharmacology / Pharmaceuticals policy / Drug safety / Serious adverse event / Adverse event / Clinical Trials Directive / Pharmacovigilance / Clinical research / Research / Pharmaceutical industry

Communication from the Commission — Detailed guidance on the collection, verification and presentation of adverse event/reaction reports arising from clinical trials on medicinal products for human use (CT-3)

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-10-09 09:00:40
244Pharmaceutics / Science / EudraCT / Clinical trial / Clinical Trials Directive / Adverse event / Serious adverse event / Clinical research / Research / Pharmaceutical industry

Ref. Ares[removed][removed]EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products – quality, safety and efficacy

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-10-09 09:00:44
245Pharmacology / Pharmaceutical sciences / Science / Drug safety / Design of experiments / Serious adverse event / Clinical trial / Pharmacovigilance / Adverse event / Clinical research / Research / Pharmaceutical industry

Item / Section number Comment Item 41

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-10-09 09:33:02
246Pharmaceutics / Science / ClinicalTrials.gov / EudraCT / Novo Nordisk / Clinical trial / European Federation of Pharmaceutical Industries and Associations / Serious adverse event / Adverse event / Clinical research / Pharmaceutical industry / Research

Page 1 of 2 FUEHRING Stefan (SANCO) From: MERJ (Merete Jørgensen) [[removed]] Sent: jeudi 30 septembre[removed]:18 To: SANCO PHARMACEUTICALS Cc: LBWR (Lill-Brith von Arx); MERS (Merete Schmiegelow); VBJE (Vibe

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-10-09 09:32:48
247Pharmaceutical sciences / Health / Pharmacology / Serious adverse event / Adverse effect / Adverse event / Medicines and Healthcare products Regulatory Agency / Clinical trial / Pharmacovigilance / Clinical research / Research / Pharmaceutical industry

Joint Research Compliance Office This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled.

Add to Reading List

Source URL: workspace.imperial.ac.uk

Language: English - Date: 2013-07-08 06:36:01
248Clinical Trials Directive / EudraLex / Clinical trial / Good Clinical Practice / Pharmacovigilance / EudraCT / Ethics Committee / Medical research / Serious adverse event / Clinical research / Research / Health

EUROPEAN COMMISSION Brussels, [removed]SWD[removed]final VOLUME II (Annexes)

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-10-09 09:29:42
249Clinical research / Medicine / Pharmaceuticals policy / Drug safety / Pharmaceutical industry / Pharmacovigilance / EudraVigilance / European Medicines Agency / Serious adverse event / Pharmaceutical sciences / Pharmacology / Health

Microsoft Word - vol_9b_2011-10.doc

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-10-09 08:59:17
250Health / Clinical research / Pharmaceutical industry / Drug safety / Pharmacy / Pharmacovigilance / Adverse event / Serious adverse event / Medical device / Pharmacology / Medicine / Pharmaceutical sciences

KPO SOLUTIONS Overview To streamline our processes we have set up a Knowledge Process Outsourcing

Add to Reading List

Source URL: www.medhimalayas.com

Language: English - Date: 2009-10-13 01:47:50
UPDATE